THE CHEMOURS COMPANY |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.89 USD | +1.74% |
|
+1.70% | -14.84% |
| Apr. 10 | North American Morning Briefing : Traders Await -2- | DJ |
| Apr. 09 | BMO Capital Upgrades Chemours to Outperform From Underperform, Raises Price Target to $34 From $19 | MT |
Financials (USD)
| Sales 2024 * | 5.85B | Sales 2025 * | 6.43B | Capitalization | 3.93B |
|---|---|---|---|---|---|
| Net income 2024 * | 247M | Net income 2025 * | 532M | EV / Sales 2024 * | 1.2 x |
| Net Debt 2024 * | 3.07B | Net Debt 2025 * | 2.98B | EV / Sales 2025 * | 1.07 x |
| P/E ratio 2024 * |
16.3
x | P/E ratio 2025 * |
7.68
x | Employees | 6,200 |
| Yield 2024 * |
4.74% | Yield 2025 * |
4.99% | Free-Float | 74.81% |
More Fundamentals
* Assessed data
More news
Latest transcript on The Chemours Company
More recommendations
More press releases
| 1 day | +2.01% | ||
| 1 week | +1.58% | ||
| Current month | +0.65% | ||
| 1 month | -5.13% | ||
| 3 months | -11.19% | ||
| 6 months | +5.80% | ||
| Current year | -16.20% |
1 week
25.83
26.94
1 month
24.2429.07
Current year
15.1032.70
1 year
15.1039.05
3 years
15.1044.95
5 years
7.0244.95
10 years
3.0658.08
| Managers | Title | Age | Since |
|---|---|---|---|
Denise Dignam
CEO | Chief Executive Officer | 58 | 14-12-31 |
Matthew Abbott
DFI | Director of Finance/CFO | 48 | 16-12-31 |
Brandon Ontjes
IRC | Investor Relations Contact | - | 15-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mary Cranston
BRD | Director/Board Member | 76 | 15-06-18 |
Curtis Anastasio
BRD | Director/Board Member | 67 | 15-06-18 |
Sean Keohane
BRD | Director/Board Member | 56 | 17-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.46% | 3,524 M€ | +2.60% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 26.86 | +1.63% | 355 930 |
| 24-04-22 | 26.43 | +2.01% | 1,038,898 |
| 24-04-19 | 25.91 | -2.15% | 899,985 |
| 24-04-18 | 26.48 | +0.42% | 1,233,471 |
| 24-04-17 | 26.37 | -0.15% | 1,147,005 |
Delayed Quote Nyse, April 22, 2024 at 04:00 pm EDT
More quotes
The Chemours Company is a provider of performance chemicals, which is engaged in providing customized solutions with a range of industrial and specialty chemicals products for markets. Its segments include Titanium Technologies, Thermal & Specialized Solutions and Advanced Performance Materials. Titanium Technologies segment is a provider of titanium dioxide pigment, a premium white pigment used to deliver whiteness, brightness, opacity and protection in various applications. The Thermal & Specialized Solutions segment is a provider of refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment is a provider of high-end polymers and advanced materials. Its flagship products include brands such as Ti-Pure, Opteon, Freon, Teflon, Viton, Nafion, and Krytox. It operates in approximately 28 production facilities located in eight countries and serves 2,700 customers across a range of end markets in 110 countries.
Sector
Diversified Chemicals
Calendar
2024-04-28
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
26.43
USD
Average target price
31.44
USD
Spread / Average Target
+18.97%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.20% | 3.93B | |
| +4.92% | 78.85B | |
| +4.47% | 48.55B | |
| -3.93% | 30.9B | |
| +6.57% | 17.68B | |
| -10.55% | 11.46B | |
| +8.06% | 11.41B | |
| +5.77% | 9.93B | |
| -6.43% | 9.77B | |
| +5.95% | 9.12B |
- Stock Market
- Equities
- CC Stock
